423 related articles for article (PubMed ID: 22867056)
1. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
4. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
Padrela L; de Azevedo EG; Velaga SP
Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization.
Cao F; Amidon GL; Rodriguez-Hornedo N; Amidon GE
Mol Pharm; 2016 Mar; 13(3):1030-46. PubMed ID: 26877267
[TBL] [Abstract][Full Text] [Related]
6. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
8. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Basis of Cocrystal Dissolution Advantage.
Cao F; Amidon GL; Rodríguez-Hornedo N; Amidon GE
J Pharm Sci; 2018 Jan; 107(1):380-389. PubMed ID: 28989017
[TBL] [Abstract][Full Text] [Related]
11. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
Zhang GC; Lin HL; Lin SY
J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
[TBL] [Abstract][Full Text] [Related]
12. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
[TBL] [Abstract][Full Text] [Related]
13. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
Huang N; Rodríguez-Hornedo N
J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
15. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals.
Gao Y; Gao J; Liu Z; Kan H; Zu H; Sun W; Zhang J; Qian S
Int J Pharm; 2012 Nov; 438(1-2):327-35. PubMed ID: 22989978
[TBL] [Abstract][Full Text] [Related]
16. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
Avdeef A
Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
[TBL] [Abstract][Full Text] [Related]
17. Formation of Indomethacin-Saccharin Cocrystals during Wet Granulation: Role of Polymeric Excipients.
Tanaka R; Duggirala NK; Hattori Y; Otsuka M; Suryanarayanan R
Mol Pharm; 2020 Jan; 17(1):274-283. PubMed ID: 31756100
[TBL] [Abstract][Full Text] [Related]
18. Effect of varying quantities of polymer on preparation and stability evaluation of carbamazepine cocrystals with dicarboxylic acid coformers.
Wasim M; Mannan A; Ullah K; Yameen MA; Latif M; Ahmad T; Ullah M; Amirzada MI; Khan HU; Maheen S; Khan SA; Jamil QA; Bin Asad MHH; Hussain I
Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1755-1761. PubMed ID: 33612458
[TBL] [Abstract][Full Text] [Related]
19. Hansen solubility parameter as a tool to predict cocrystal formation.
Mohammad MA; Alhalaweh A; Velaga SP
Int J Pharm; 2011 Apr; 407(1-2):63-71. PubMed ID: 21256944
[TBL] [Abstract][Full Text] [Related]
20. Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.
Box KJ; Comer J; Taylor R; Karki S; Ruiz R; Price R; Fotaki N
AAPS PharmSciTech; 2016 Apr; 17(2):245-51. PubMed ID: 26208438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
